Authors

Adam C. Berger, MD, FACS, is the chief of melanoma and soft tissue surgical oncology at Rutgers Cancer Institute.

Sabrina Serani is the assistant managing editor for Targeted Oncology.

Marco A. Ruiz Andia, M.D., MPH, FACP, FIDSA, is chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute as well as an attending physician in the BMT unit. Dr. Ruiz is a medical oncologist specializing in the treatment of hematologic cancers, including leukemia, lymphoma, myelodysplastic syndrome and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). He is an associate professor at Florida International University’s Herbert Wertheim College of Medicine.

Idoroenyi Amanam, MD, is a hematologist-oncologist at City of Hope Comprehensive Cancer Center in Duarte, CA. Amanam obtained his medical degree from Meharry Medical College in Nashville, TN. He completed his training at St. Mary-UCLA Internal Medicine Residency. Following residency, Amanam completed his hematology and oncology training at the City of Hope/UCLA-Harbor combined program.

Nancy Y. Lee, MD, FASTRO is a radiation oncologist who holds the positions of vice president of Department of Radiation Oncology, and service chief, for Head & Neck Radiation Oncology and Proton Therapy at Memorial Sloan Kettering Cancer Center.

Murugesan Manoharan, MD, FRACS, is a surgical urologic oncologist and chief of urologic oncology surgery at Miami Cancer Institute. He also serves as chair of the Department of Urology at Baptist Health South Florida and is a professor of urology at Herbert Wertheim College of Medicine, Florida International University.

Maisey Ratcliffe, MPH, is a clinical research coordinator III at Emory University.